These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6480771)

  • 1. High-performance liquid chromatographic determination of 3,4-diaminopyridine in human plasma.
    Lamiable D; Millart H; Lemeignan M; Vistelle R
    J Chromatogr; 1984 Jul; 309(1):222-4. PubMed ID: 6480771
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of 4-aminopyridine and 3,4-diaminopyridine in rat cerebrospinal fluid and serum.
    Lamiable D; Millart H
    J Chromatogr; 1983 Jan; 272(1):221-5. PubMed ID: 6841545
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of 2,4-diaminopyridine in plasma and urine.
    Biessels PT; Agoston S; Horn AS
    J Chromatogr; 1987 Oct; 421(2):392-5. PubMed ID: 3429592
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of 3,4-diaminopyridine in human plasma by high-performance liquid chromatography.
    Kamali F; Nicholson E
    J Pharm Biomed Anal; 1995 May; 13(6):791-4. PubMed ID: 7669834
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats.
    Lemeignan M; Millart H; Lamiable D; Molgo J; Lechat P
    Brain Res; 1984 Jun; 304(1):166-9. PubMed ID: 6744035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 3,4-diaminopyridine in human serum by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Leslie J; Bever CT
    J Chromatogr; 1989 Nov; 496(1):214-22. PubMed ID: 2556419
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.
    Lundh H; Nilsson O; Rosén I
    Neurology; 1984 Oct; 34(10):1324-30. PubMed ID: 6541305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a CE assay for the analysis of isomeric aminopyridines and diaminopyridines.
    Sabbah S; Scriba GK
    J Pharm Biomed Anal; 2001 Feb; 24(4):695-703. PubMed ID: 11272328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-chromatographic determination of 4-aminopyridine in serum, saliva, and urine.
    Uges DR; Bouma P
    Clin Chem; 1981 Mar; 27(3):437-40. PubMed ID: 7471395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of some new aminopyridines on mammalian non-myelinated nerve fibres.
    Den Hertog A; Pielkenrood J; Biessels P; Agoston S
    Eur J Pharmacol; 1983 Oct; 94(3-4):353-5. PubMed ID: 6653665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment.
    Peterson C; Gibson GE
    J Neurochem; 1984 Jan; 42(1):248-53. PubMed ID: 6689690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of age-related neurochemical and behavioral deficits by 3,4-diaminopyridine.
    Peterson C; Gibson GE
    Neurobiol Aging; 1983; 4(1):25-30. PubMed ID: 6877484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 3,4-diaminopyridine and 4-aminopyridine in the anaesthetized cat.
    Durant NN; Nguyen N; Lee C; Katz RL
    Eur J Pharmacol; 1982 Oct; 84(3-4):215-9. PubMed ID: 6293848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.
    Siegel LS; Price JI
    Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion-pair high-performance liquid chromatographic assay of 4-aminopyridine in serum.
    Shinohara Y; Miller RD; Castagnoli N
    J Chromatogr; 1982 Jul; 230(2):363-72. PubMed ID: 7107782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive trace-first liquid chromatographic determination of 4-aminopyridine in 3,4-diaminopyridine.
    Perry JA; Chang M
    J Pharm Sci; 1990 May; 79(5):437-9. PubMed ID: 2352165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of some pharmacological properties of 4-aminopyridine and 3,4-diaminopyridine in vivo.
    Houston T; Pleuvry BJ
    Br J Anaesth; 1984 Oct; 56(10):1139-42. PubMed ID: 6148094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a capillary electrophoresis assay for the determination of 3,4-diaminopyridine and 4-aminopyridine including related substances.
    Sabbah S; Scriba GK
    J Chromatogr A; 2001 Jan; 907(1-2):321-8. PubMed ID: 11217039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis.
    Polman CH; Bertelsmann FW; de Waal R; van Diemen HA; Uitdehaag BM; van Loenen AC; Koetsier JC
    Arch Neurol; 1994 Nov; 51(11):1136-9. PubMed ID: 7980110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound driven synthesis of reversed-phase stationary phases for liquid chromatography using 4-dimethyl-aminopyridine as acid-acceptor.
    Sentell KB; Barnes KW; Dorsey JG
    J Chromatogr; 1988 Nov; 455():95-104. PubMed ID: 3235626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.